# Vaxcyte, Inc.: Form 8-K, filed Jun 16, 2020

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2020-06-16
- Accepted by EDGAR: Jun 16, 2020, 16:30 ET
- Period: 2020-06-16
- Accession: 0001193125-20-170425
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000119312520170425/d944845d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000119312520170425/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000119312520170425/d944845d8k.htm

Filed Jun 16, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-170425. Last ingested by Listed: Nov 14, 2026, 19:29 ET. No prices; not investment advice.
